Importantly, some specific mediators of the off-target effects of using Nolvadex for gyno have been identified, such as NRF2 signaling, caspase-1 activation and cholesterol redistribution. These pathways are known to control macrophage immunometabolism and inflammatory responses, thus being essential in containing infections.